Edition:
United Kingdom

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

11.69USD
9:00pm BST
Change (% chg)

$0.06 (+0.52%)
Prev Close
$11.63
Open
$11.57
Day's High
$11.81
Day's Low
$11.41
Volume
69,931
Avg. Vol
201,399
52-wk High
$14.45
52-wk Low
$2.54

Latest Key Developments (Source: Significant Developments)

Fate Therapeutics Announces Pricing Of Public Offering Of Common Stock
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - Fate Therapeutics Inc ::FATE THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 9.53 MILLION COMMON SHARES PRICED AT $4.20PER SHARE.  Full Article

Fate Therapeutics reports Q2 2016 financial results
Monday, 8 Aug 2016 

Fate Therapeutics Inc : Fate Therapeutics reports second quarter 2016 financial results . Q2 revenue $1.0 million versus I/B/E/S view $866,000 . Says Ind Filing For Allogeneic Memory Like NK cell cancer immunotherapy planned for 2016 .Qtrly loss per share $0.29.  Full Article

Fate Therapeutics says $10.3 million common stock private placement
Monday, 8 Aug 2016 

Fate Therapeutics Inc: Fate Therapeutics announces $10.3 million common stock private placement . Investors have agreed to purchase 5.3 million shares of company's common stock at a price of $1.96 per share .Expects to use proceeds from transaction primarily to advance its pipeline of programmed cellular immunotherapies among others.  Full Article

BRIEF-Fate Therapeutics Files For Mixed Shelf Of Up To $150 Million

* FATE THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING Source text: (https://bit.ly/2KD5gGz) Further company coverage: